Then, we integrated the two screening models, took their intersection, and discovered three HER2+ BC-related prognostic genes (FGF9, SF3B4, and EPCAM) (Figure 2i) that we dubbed EPGs. This evidence concerns the gene EPCAM and breast cancer.